TNXPNasdaq United States
Market cap
$191.768 M
$12.03 +3.26%
Close of 7 Aug 2026
Revenue
$13.1M
#3115 by revenue
Earnings
-$124.0M
Loss-making
Shares outstanding
13,405,401
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Tonix Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.